PROF
Income statement / Annual
Last year (2024), Profound Medical Corp.'s total revenue was $10.68 M,
an increase of 48.35% from the previous year.
In 2024, Profound Medical Corp.'s net income was -$26.48 M.
See Profound Medical Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$10.68 M |
$7.20 M |
$6.68 M |
$6.87 M |
$7.30 M |
$4.23 M |
$1.91 M |
$3.90 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$3.64 M
|
$2.82 M
|
$3.66 M
|
$3.92 M
|
$3.83 M
|
$1.81 M
|
$1.31 M
|
$2.41 M
|
$187.01 K
|
$119.03 K
|
| Gross Profit |
$7.04 M
|
$4.38 M
|
$3.02 M
|
$2.95 M
|
$3.47 M
|
$2.42 M
|
$604.82 K
|
$1.49 M
|
-$187.01 K
|
-$119.03 K
|
| Gross Profit Ratio |
0.66
|
0.61
|
0.45
|
0.43
|
0.48
|
0.57
|
0.32
|
0.38
|
0
|
0
|
| Research and Development Expenses |
$16.97 M
|
$14.38 M
|
$14.69 M
|
$15.28 M
|
$9.91 M
|
$9.54 M
|
$7.54 M
|
$7.66 M
|
$7.43 M
|
$3.70 M
|
| General & Administrative Expenses |
$0.00
|
$9.17 M
|
$9.47 M
|
$10.31 M
|
$7.57 M
|
$5.88 M
|
$4.89 M
|
$4.72 M
|
$4.20 M
|
$4.39 M
|
| Selling & Marketing Expenses |
$0.00
|
$9.45 M
|
$8.47 M
|
$7.65 M
|
$4.86 M
|
$2.14 M
|
$3.00 M
|
$3.12 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$23.13 M
|
$18.62 M
|
$17.93 M
|
$17.97 M
|
$12.43 M
|
$8.01 M
|
$7.89 M
|
$7.84 M
|
$4.20 M
|
$4.39 M
|
| Other Expenses |
$0.00
|
$0.00
|
$2.52 M
|
$0.00
|
$0.00
|
$0.00
|
$3.76 K
|
$3.65 K
|
$1.57 K
|
$0.00
|
| Operating Expenses |
$40.10 M
|
$33.00 M
|
$32.62 M
|
$33.24 M
|
$22.34 M
|
$17.56 M
|
$15.43 M
|
$15.51 M
|
$11.64 M
|
$8.09 M
|
| Cost And Expenses |
$43.74 M
|
$35.82 M
|
$36.28 M
|
$37.16 M
|
$26.17 M
|
$19.36 M
|
$16.74 M
|
$17.92 M
|
$11.64 M
|
$8.09 M
|
| Interest Income |
$0.00
|
$1.64 M
|
$1.05 M
|
$205.00 K
|
$692.00 K
|
$368.46 K
|
$355.20 K
|
$101.58 K
|
$117.25 K
|
$99.24 K
|
| Interest Expense |
$0.00
|
$932.80 K
|
$174.00 K
|
$303.00 K
|
$543.00 K
|
$544.75 K
|
$755.37 K
|
$1.07 M
|
$615.87 K
|
$4.05 M
|
| Depreciation & Amortization |
$0.00
|
$1.15 M
|
$2.09 M
|
$2.36 M
|
$2.06 M
|
$2.01 M
|
$1.68 M
|
$876.42 K
|
$187.01 K
|
$85.77 K
|
| EBITDA |
-$33.06 M |
-$26.78 M |
-$25.55 M |
-$28.65 M |
-$19.50 M |
-$12.53 M |
-$13.24 M |
-$16.78 M |
-$15.56 M |
-$11.15 M |
| EBITDA Ratio |
-3.1
|
-3.72
|
-3.82
|
-4.17
|
-2.67
|
-2.96
|
-6.93
|
-4.3
|
0
|
0
|
| Operating Income Ratio |
-3.1
|
-3.97
|
-4.43
|
-4.41
|
-2.58
|
-3.58
|
-7.76
|
-4.52
|
0
|
0
|
| Total Other Income/Expenses Net |
$6.58 M
|
-$81.00 K
|
$3.74 M
|
-$303.00 K
|
$2.42 M
|
-$171.00 K
|
-$247.73 K
|
$2.72 M
|
-$672.30 K
|
-$1.10 M
|
| Income Before Tax |
-$26.48 M
|
-$28.70 M
|
-$28.38 M
|
-$30.59 M
|
-$21.58 M
|
-$15.31 M
|
-$15.07 M
|
-$14.91 M
|
-$12.14 M
|
-$12.32 M
|
| Income Before Tax Ratio |
-2.48
|
-3.99
|
-4.25
|
-4.45
|
-2.95
|
-3.62
|
-7.89
|
-3.82
|
0
|
0
|
| Income Tax Expense |
-$2.00 K
|
-$128.00 K
|
$287.00 K
|
$105.00 K
|
$45.00 K
|
$148.42 K
|
$169.44 K
|
$58.94 K
|
$10.46 K
|
-$523.22 K
|
| Net Income |
-$26.48 M
|
-$28.57 M
|
-$28.67 M
|
-$30.70 M
|
-$21.62 M
|
-$15.46 M
|
-$15.24 M
|
-$14.97 M
|
-$12.15 M
|
-$11.80 M
|
| Net Income Ratio |
-2.48
|
-3.97
|
-4.29
|
-4.47
|
-2.96
|
-3.65
|
-7.98
|
-3.84
|
0
|
0
|
| EPS |
-1.12 |
-1.35 |
-1.38 |
-1.5 |
-1.25 |
-1.39 |
-1.52 |
-2.44 |
-2.93 |
-4.98 |
| EPS Diluted |
-1.12 |
-1.35 |
-1.38 |
-1.5 |
-1.25 |
-1.39 |
-1.52 |
-2.44 |
-2.93 |
-4.98 |
| Weighted Average Shares Out |
$24.77 M
|
$21.18 M
|
$20.83 M
|
$20.46 M
|
$17.29 M
|
$11.09 M
|
$10.04 M
|
$6.14 M
|
$4.15 M
|
$2.37 M
|
| Weighted Average Shares Out Diluted |
$24.77 M
|
$21.18 M
|
$20.83 M
|
$20.47 M
|
$17.29 M
|
$11.09 M
|
$10.04 M
|
$6.14 M
|
$4.15 M
|
$2.37 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
